Archives for July 3, 2006

← 2006

ChemGenex and MolecularMD team up in drug resistance deal

By  Wai Lang Chu

ChemGenex has teamed up with MolecularMD in a deal that focuses on a drug resistance mutation seen in chronic myeloid leukemia (CML) patients, which has seen these sufferers no longer respond to Gleevec, a popular cancer treatment.

Frost & Sullivan crowns Cytogenix king of DNA production

By  Gregory Roumeliotis

Frost & Sullivan has awarded biopharmaceutical firm Cytogenix with its 2006 award for innovation in biotechnology processing for its cell-free manufacturing method that enables generation of large quantities of high-purity DNA in small highly...

NBS launches new laboratory shaker range

By  Wai Lang Chu

New Brunswick Scientific (NBS) has introduced two new benchtop incubator shakers, the first in a range of eight new models replacing the original C-Line. The shakers have been designed to allow reproducible results all the way down the cell line.

New APIs call for new dissolution testing methods

By  Gregory Roumeliotis

A new generation of drugs that target specific areas of the body has created new challenges for dissolution testing, as many recent active pharmaceutical ingredients (APIs) are poorly soluble in traditional media and need novel testing procedures.

Staff costs dragging big pharma down

By  Kirsty Barnes

As financial pressures continue to plague the pharma industry, firms should consider taking more advantage of sourcing staff in cheap labour markets in order to save a buck.

FDA hits sanofi pasteur with warning letter

By  Gregory Roumeliotis

Sanofi pasteur's vaccine manufacturing plant in Pennsylvania, where half of America's influenza vaccines are made, has been served with a warning letter by the US Food and Drug Administration (FDA), asking for measures to ensure batches of its flu...

New toolkit to assist drug quality assurance

By  Kirsty Barnes

Best Practices Research and Consulting have put together a toolkit to help pharma companies improve manufacturing quality assurance and efficiency.

Applied Biosystems acquires new DNA sequencing technology

By  Wai Lang Chu

Applied Biosystems (AB) is to acquire Agencourt Personal Genomics (APG) for approximately $120m (€94m) in cash in which the life science specialists will gain a novel, high throughput approach with applications in DNA sequencing, gene expression, and...

ESF's EuroBioFund boosts European life sciences

By  Wai Lang Chu

European life sciences received an unexpected boost as the European Science Foundation launched an initiative to help promote and coordinate interaction among European life sciences researchers and funders.

Checklist for choosing CROs in Asia Pacific

By  Kirsty Barnes

As clinical trial activity in the Asia Pacific region continues to boom, Novotech, the largest Australian owned contract research organisation (CRO) has presented a checklist to help pharma firms minimise risk when choosing a partner.

India introduces new rules on device manufacturing

By  Kirsty Barnes

New guidelines for the import and manufacture of medical devices in India have now come into effect, aimed at increasing world confidence in medical devices made in the region.